Celledonia™ Applications

Celledonia’s rapid assessment helps reduce development and technology transfer timelines, manufacturing costs, labour and time-to-market.

Discover how predictive cell analysis can transform your workflow.

Click an application below to find out more.

Monoclonal Antibodies Cell Line Development

Viral Vector Production

Allogeneic cell therapy

Autologous cell therapy

See for yourself …

Cytomos AuraCyt™ platform technology offers enormous potential to both ATMPs as well as Biologics from a bioprocess development, productivity, stability and speed-to-patient perspective.

To find out more about our revolutionary technology, please click below and complete our form.